Monday, 18 Jan 2021


Study: Minimum dose of hydromethylthionine could slow cognitive decline in mild-to-moderate Alzheimer’s

In a paper published in today’s online issue of the Journal of Alzheimer’s Disease, TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer’s disease. These results showed that, even at […]

New migraine medications could endanger patients with high blood pressure

New migraine medications block αCGRP, a neuropeptide which causes vasodilation, for example in the meninges. The very same peptide, which is formed in the muscles during physical activity, protects the heart—which is vital for people with chronic high blood pressure. The innovative migraine prophylaxis could endanger these people, as researchers at the University of Zurich […]

Codeine-related poisonings in Australia have halved since it became prescription-only

The rescheduling of all codeine-containing products as prescription-only medications from 1 February 2018 has been associated with a 53 percent drop in codeine-related presentations at a major Brisbane hospital’s toxicology unit, according to the authors of research published online today by the Medical Journal of Australia. A total of 2235 patients presented to the Princess […]

New opioid library unveiled to help address epidemic

A new curated library, activated today, provides a centralized toolkit for policymakers, patients and health care professionals working to address the nation’s opioid epidemic. The epidemic kills tens of thousands of Americans annually, yet decision-makers report that they’ve struggled to make sense of an overwhelming and often-bewildering array of data. It can be hard to […]

Researchers, policymakers outline new framework for opioid use disorder treatment

Every day, more than 100 Americans lose their lives to the opioid crisis, and researchers from across the nation are racing to find solutions. One of the latest strategies—a cascade of care model for the State of Rhode Island—was developed collaboratively by a diverse group of stakeholders, including experts from Brown University, state agency leaders […]

Regular use of prescription drugs for pain and sleep increases frailty risk by 95 percent

Researchers from the Oregon Research Institute (ORI) and Florida Atlantic University (FAU) are the first to demonstrate statistically significant links between self-reported regular use of prescription drugs for pain and/or sleep, and longitudinal risk of frailty in adults ages 65 and older. Frailty consists of deficits in a variety of functional measures, and is a […]

Australia should adopt pill testing, but lacks the political will to do so

Despite harm reduction being one of the three pillars of the National Drug Strategy, Australian governments are shying away from pill-testing despite evidence suggesting it provides a useful tool for both direct harm reduction, as well as indirect harm reduction through the increased education of a hard-to-reach group of drug users, according to the authors […]

Expert: Opioid settlements come with limitations

The nation’s three biggest drug distributors and a major drugmaker agreed to a $260 million settlement Monday over the toll taken by opioids in two Ohio counties, averting the first federal trial over the crisis. This settlement is a promising start, according to a drug policy expert at Rice University’s Baker Institute for Public Policy. […]

New chemical weapon to combat cancer

UNIGE researchers have discovered a new combination of drugs that is effective in fighting cancer cells without affecting healthy cells. The fight against cancer involves eradicating cancer cells but current treatments inevitably have negative consequences on healthy cells. Patients often develop a resistance to the drugs and suffer from side effects due to the doses […]

Recent Posts